Sierra Oncology Inc (SRRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | SRRA | ARDX | SLNO | ||
Company | Sierra Oncology Inc | Ardelyx Inc | Soleno Therapeutics Inc | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 54.98 | 6.35 | 37.09 | ||
High | 55.17 | 6.59 | 38.33 | ||
Low | 54.98 | 6.30 | 37.09 | ||
Last | 54.99 | 6.42 | 37.89 | ||
Change | +0.02 | +0.11 | +0.55 | ||
% Change | +0.04% | +1.74% | +1.47% | ||
Volume | 862,800 | 5,484,500 | 138,600 | ||
20-Day Average Volume | 396,690 | 5,245,460 | 273,740 | ||
Previous Close | 54.97 | 6.31 | 37.34 | ||
Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
Has Options | No | Yes | Yes | ||
Technicals | |||||
20-Day Moving Average | 54.91 | 6.89 | 39.25 | ||
20-Day Raw Stochastic | 62.96% | 11.59% | 18.78% | ||
20-Day Relative Strength | 77.35% | 35.82% | 42.15% | ||
Weighted Alpha | +89.10 | +12.69 | +67.97 | ||
Today's Opinion | 100% Buy | 8% Sell | 8% Buy | ||
Previous Opinion | 100% Buy | 8% Sell | 8% Buy | ||
Last Month's Opinion | 100% Buy | 40% Buy | 40% Buy | ||
Performance | |||||
5-Days | |||||
%Chg | +0.07% since 06/23/22 | -0.93% since 04/19/24 | +1.04% since 04/19/24 | ||
Low | 54.65 on 06/24/22 | 6.23 on 04/25/24 | 37.09 on 04/26/24 | ||
High | 55.19 on 06/24/22 | 6.72 on 04/23/24 | 40.74 on 04/24/24 | ||
1-Month | |||||
%Chg | +0.38% since 05/27/22 | -13.48% since 03/26/24 | -12.29% since 03/26/24 | ||
Low | 54.58 on 05/31/22 | 6.23 on 04/25/24 | 36.61 on 04/19/24 | ||
High | 55.19 on 06/24/22 | 7.87 on 04/05/24 | 44.17 on 03/27/24 | ||
3-Month | |||||
%Chg | +69.83% since 03/30/22 | -29.14% since 01/26/24 | -18.69% since 01/26/24 | ||
Low | 30.87 on 03/31/22 | 6.23 on 04/25/24 | 36.61 on 04/19/24 | ||
High | 55.19 on 06/24/22 | 10.13 on 02/12/24 | 53.82 on 02/28/24 | ||
6-Month | |||||
%Chg | +144.40% since 12/30/21 | +78.33% since 10/26/23 | +57.94% since 10/26/23 | ||
Low | 14.91 on 01/24/22 | 3.43 on 11/10/23 | 21.30 on 11/06/23 | ||
High | 55.19 on 06/24/22 | 10.13 on 02/12/24 | 53.82 on 02/28/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 1,342,801 | 1,493,844 | 1,265,942 | ||
Shares Outstanding, K | 24,419 | 232,686 | 33,411 | ||
Annual Sales | 0 | 124,460,000 | 0 | ||
Annual Net Income | -94,660,000 | -66,070,000 | -38,990,000 | ||
Last Quarter Sales | 0 | 34,360,000 | 0 | ||
Last Quarter Net Income | -27,930,000 | -28,800,000 | -11,300,000 | ||
60-Month Beta | 0.01 | 0.85 | -1.56 | ||
Per-Share Information | |||||
Most Recent Earnings | -1.33 on 05/06/22 | -0.12 on 02/22/24 | -0.33 on 03/06/24 | ||
Latest Earnings Date | 08/04/22 | 05/02/24 | 05/14/24 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |